Opus Genetics
IRD
31 hedge funds and large institutions have $3.2M invested in Opus Genetics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 3 closing their positions.
6% less funds holding
Funds holding: 33 → 31 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
49% less capital invested
Capital invested by funds: $6.23M → $3.2M (-$3.03M)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$287K |
| 2 |
Wolverine Trading
Chicago,
Illinois
|
+$6.75K |
| 3 |
BMC
Benin Management Corp
Wilton,
Connecticut
|
+$3.34K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.12K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$638K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$448K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$362K |
| 4 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$30K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$16.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NPT
26
Nixon Peabody Trust
Boston,
Massachusetts
| $1K | – | – | – |
|
|
27
Wells Fargo
San Francisco,
California
| $1K | +$1.3K | +16 | +178% |
|
|
CCM
28
Condor Capital Management
Martinsville,
New Jersey
| – | -$30K | -302 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$244 | -3 | -27% |
|
IRD Hedge Fund Activity: Q4 2016 in Review
31 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2016, worth a combined $3.2M — down 49% from $6.23M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of IRD and 2 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $287K. The largest seller was Anson Funds Management, cutting an estimated $638K.
- 31 institutional investors held Opus Genetics (IRD) as of Q4 2016, down from 33 in Q3 2016.
- Funds reported $3.2M of Opus Genetics stock for Q4 2016, down 49% quarter-over-quarter.
- 2 funds opened new Opus Genetics positions in Q4 2016 and 3 closed out, a net change of -1 holder.
- The largest Opus Genetics buyer in Q4 2016 was Renaissance Technologies, an estimated $287K added.
- The largest Opus Genetics seller in Q4 2016 was Anson Funds Management, an estimated $638K sold.
Based on aggregated 13F filings for Q4 2016.